USD 2.67
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -4.15 Million USD | -283.21% |
2022 | -1.08 Million USD | -63.01% |
2021 | -665 Thousand USD | 82.77% |
2020 | -3.85 Million USD | -350.26% |
2019 | 1.54 Million USD | -66.36% |
2018 | 4.58 Million USD | -25.11% |
2017 | 6.12 Million USD | -8.34% |
2016 | 6.67 Million USD | 341.91% |
2015 | 1.51 Million USD | -52.87% |
2014 | 3.2 Million USD | -15.74% |
2013 | 3.8 Million USD | 27.71% |
2012 | 2.97 Million USD | -14.61% |
2011 | 3.48 Million USD | 33.5% |
2010 | 2.61 Million USD | 71.13% |
2009 | 1.52 Million USD | -48.55% |
2008 | 2.96 Million USD | -33.79% |
2007 | 4.48 Million USD | -8.54% |
2006 | 4.9 Million USD | 21.09% |
2005 | 4.04 Million USD | 46.48% |
2004 | 2.76 Million USD | 126.86% |
2003 | 1.21 Million USD | -2.98% |
2002 | 1.25 Million USD | 440.03% |
2001 | 232.52 Thousand USD | -86.31% |
2000 | 1.69 Million USD | -26.15% |
1999 | 2.3 Million USD | -4.17% |
1998 | 2.4 Million USD | -4.0% |
1997 | 2.5 Million USD | 0.0% |
1996 | 2.5 Million USD | 56.25% |
1995 | 1.6 Million USD | -11.11% |
1994 | 1.8 Million USD | 80.0% |
1993 | 1 Million USD | 300.0% |
1992 | -500 Thousand USD | 66.67% |
1991 | -1.5 Million USD | 28.57% |
1990 | -2.1 Million USD | -110.0% |
1989 | -1 Million USD | 44.44% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -688 Thousand USD | 27.2% |
2024 Q2 | -827 Thousand USD | -20.2% |
2023 Q4 | -945 Thousand USD | 54.98% |
2023 Q2 | -726 Thousand USD | -89.06% |
2023 Q1 | -384 Thousand USD | 44.19% |
2023 Q3 | -2.09 Million USD | -189.12% |
2023 FY | -4.15 Million USD | -283.21% |
2022 Q3 | -97 Thousand USD | 71.3% |
2022 Q1 | 39 Thousand USD | 102.41% |
2022 Q2 | -338 Thousand USD | -966.67% |
2022 Q4 | -688 Thousand USD | -609.28% |
2022 FY | -1.08 Million USD | -63.01% |
2021 Q4 | -1.62 Million USD | -319.35% |
2021 Q2 | 134 Thousand USD | 61.45% |
2021 Q3 | 739 Thousand USD | 451.49% |
2021 FY | -665 Thousand USD | 82.77% |
2021 Q1 | 83 Thousand USD | 115.29% |
2020 FY | -3.85 Million USD | -350.26% |
2020 Q4 | -543 Thousand USD | 50.95% |
2020 Q3 | -1.1 Million USD | 46.0% |
2020 Q2 | -2.05 Million USD | -1189.31% |
2020 Q1 | -159 Thousand USD | 70.0% |
2019 FY | 1.54 Million USD | -66.36% |
2019 Q2 | 768 Thousand USD | 22.49% |
2019 Q3 | 677 Thousand USD | -11.85% |
2019 Q4 | -530 Thousand USD | -178.29% |
2019 Q1 | 627 Thousand USD | -28.83% |
2018 FY | 4.58 Million USD | -25.11% |
2018 Q2 | 1.17 Million USD | -5.92% |
2018 Q1 | 1.25 Million USD | -46.77% |
2018 Q3 | 1.27 Million USD | 8.33% |
2018 Q4 | 881 Thousand USD | -30.9% |
2017 FY | 6.12 Million USD | -8.34% |
2017 Q4 | 2.35 Million USD | 72.29% |
2017 Q1 | 1.5 Million USD | -36.44% |
2017 Q2 | 907 Thousand USD | -39.53% |
2017 Q3 | 1.36 Million USD | 50.39% |
2016 Q4 | 2.36 Million USD | -12.85% |
2016 FY | 6.67 Million USD | 341.91% |
2016 Q3 | 2.7 Million USD | 65.75% |
2016 Q2 | 1.63 Million USD | 7068.76% |
2016 Q1 | -23.44 Thousand USD | -112.68% |
2015 Q2 | 252.32 Thousand USD | -9.08% |
2015 Q1 | 277.52 Thousand USD | -58.95% |
2015 FY | 1.51 Million USD | -52.87% |
2015 Q3 | 796.38 Thousand USD | 215.61% |
2015 Q4 | 184.93 Thousand USD | -76.78% |
2014 FY | 3.2 Million USD | -15.74% |
2014 Q1 | 756.15 Thousand USD | -12.88% |
2014 Q3 | 916.9 Thousand USD | 7.0% |
2014 Q4 | 676.1 Thousand USD | -26.26% |
2014 Q2 | 856.91 Thousand USD | 13.33% |
2013 Q4 | 867.93 Thousand USD | -17.5% |
2013 Q1 | 822.34 Thousand USD | 201.65% |
2013 Q3 | 1.05 Million USD | -1.03% |
2013 Q2 | 1.06 Million USD | 29.26% |
2013 FY | 3.8 Million USD | 27.71% |
2012 Q3 | 878.48 Thousand USD | -12.24% |
2012 Q2 | 1 Million USD | 20.97% |
2012 Q1 | 827.49 Thousand USD | 88.84% |
2012 FY | 2.97 Million USD | -14.61% |
2012 Q4 | 272.61 Thousand USD | -68.97% |
2011 Q3 | 1.09 Million USD | 0.56% |
2011 Q4 | 438.18 Thousand USD | -60.14% |
2011 Q1 | 858.48 Thousand USD | 105.88% |
2011 FY | 3.48 Million USD | 33.5% |
2011 Q2 | 1.09 Million USD | 27.34% |
2010 Q1 | 506.42 Thousand USD | -7.26% |
2010 Q4 | 416.98 Thousand USD | -48.98% |
2010 Q3 | 817.36 Thousand USD | -6.37% |
2010 FY | 2.61 Million USD | 71.13% |
2010 Q2 | 872.94 Thousand USD | 72.37% |
2009 FY | 1.52 Million USD | -48.55% |
2009 Q4 | 546.08 Thousand USD | -28.92% |
2009 Q3 | 768.3 Thousand USD | 340.59% |
2009 Q2 | 174.38 Thousand USD | 352.64% |
2009 Q1 | 38.52 Thousand USD | -77.7% |
2008 Q4 | 172.72 Thousand USD | -80.23% |
2008 Q2 | 1.03 Million USD | 16.07% |
2008 Q1 | 890 Thousand USD | -1.85% |
2008 FY | 2.96 Million USD | -33.79% |
2008 Q3 | 873.55 Thousand USD | -15.44% |
2007 Q1 | 1.03 Million USD | -11.99% |
2007 Q2 | 1.33 Million USD | 28.74% |
2007 Q3 | 1.2 Million USD | -9.21% |
2007 Q4 | 906.81 Thousand USD | -25.03% |
2007 FY | 4.48 Million USD | -8.54% |
2006 Q1 | 922.16 Thousand USD | 0.57% |
2006 Q4 | 1.17 Million USD | -16.18% |
2006 FY | 4.9 Million USD | 21.09% |
2006 Q3 | 1.4 Million USD | 0.13% |
2006 Q2 | 1.4 Million USD | 51.94% |
2005 Q3 | 982.62 Thousand USD | -18.17% |
2005 FY | 4.04 Million USD | 46.48% |
2005 Q4 | 916.9 Thousand USD | -6.69% |
2005 Q2 | 1.2 Million USD | 26.65% |
2005 Q1 | 948.14 Thousand USD | 73.78% |
2004 Q4 | 545.59 Thousand USD | -31.9% |
2004 FY | 2.76 Million USD | 126.86% |
2004 Q3 | 801.15 Thousand USD | -16.9% |
2004 Q2 | 964.04 Thousand USD | 112.82% |
2004 Q1 | 452.98 Thousand USD | 24.22% |
2003 Q4 | 364.65 Thousand USD | 4.04% |
2003 FY | 1.21 Million USD | -2.98% |
2003 Q3 | 350.49 Thousand USD | -12.11% |
2003 Q1 | 104.33 Thousand USD | -20.02% |
2003 Q2 | 398.78 Thousand USD | 282.2% |
2002 Q4 | 130.46 Thousand USD | -69.98% |
2002 Q1 | 52.43 Thousand USD | 123.7% |
2002 FY | 1.25 Million USD | 440.03% |
2002 Q2 | 638.29 Thousand USD | 1117.33% |
2002 Q3 | 434.51 Thousand USD | -31.93% |
2001 Q4 | -221.22 Thousand USD | -290.26% |
2001 Q3 | 116.27 Thousand USD | -64.58% |
2001 FY | 232.52 Thousand USD | -86.31% |
2001 Q1 | 9241.00 USD | -40.23% |
2001 Q2 | 328.23 Thousand USD | 3451.94% |
2000 Q4 | 15.46 Thousand USD | -96.57% |
2000 Q2 | 677.91 Thousand USD | 22.2% |
2000 FY | 1.69 Million USD | -26.15% |
2000 Q1 | 554.74 Thousand USD | 177.37% |
2000 Q3 | 450.47 Thousand USD | -33.55% |
1999 Q1 | 600 Thousand USD | 50.0% |
1999 Q2 | 1 Million USD | 66.67% |
1999 Q3 | 600 Thousand USD | -40.0% |
1999 Q4 | 200 Thousand USD | -66.67% |
1999 FY | 2.3 Million USD | -4.17% |
1998 Q4 | 400 Thousand USD | -33.33% |
1998 Q1 | 600 Thousand USD | -14.29% |
1998 Q2 | 800 Thousand USD | 33.33% |
1998 FY | 2.4 Million USD | -4.0% |
1998 Q3 | 600 Thousand USD | -25.0% |
1997 Q1 | 600 Thousand USD | 0.0% |
1997 FY | 2.5 Million USD | 0.0% |
1997 Q2 | 700 Thousand USD | 16.67% |
1997 Q4 | 700 Thousand USD | 75.0% |
1997 Q3 | 400 Thousand USD | -42.86% |
1996 Q1 | 400 Thousand USD | 300.0% |
1996 FY | 2.5 Million USD | 56.25% |
1996 Q4 | 600 Thousand USD | -14.29% |
1996 Q3 | 700 Thousand USD | 0.0% |
1996 Q2 | 700 Thousand USD | 75.0% |
1995 Q2 | 700 Thousand USD | 75.0% |
1995 Q4 | 100 Thousand USD | -75.0% |
1995 Q3 | 400 Thousand USD | -42.86% |
1995 Q1 | 400 Thousand USD | -20.0% |
1995 FY | 1.6 Million USD | -11.11% |
1994 Q3 | 700 Thousand USD | 16.67% |
1994 Q4 | 500 Thousand USD | -28.57% |
1994 FY | 1.8 Million USD | 80.0% |
1994 Q2 | 600 Thousand USD | 0.0% |
1994 Q1 | - USD | -100.0% |
1993 Q1 | -100 Thousand USD | 0.0% |
1993 Q2 | 200 Thousand USD | 300.0% |
1993 Q3 | 300 Thousand USD | 50.0% |
1993 Q4 | 600 Thousand USD | 100.0% |
1993 FY | 1 Million USD | 300.0% |
1992 FY | -500 Thousand USD | 66.67% |
1992 Q3 | - USD | 100.0% |
1992 Q2 | -200 Thousand USD | 50.0% |
1992 Q1 | -400 Thousand USD | 0.0% |
1992 Q4 | - USD | 0.0% |
1991 FY | -1.5 Million USD | 28.57% |
1991 Q3 | -300 Thousand USD | 0.0% |
1991 Q4 | -400 Thousand USD | -33.33% |
1991 Q2 | - USD | 100.0% |
1991 Q1 | -400 Thousand USD | 0.0% |
1990 Q3 | - USD | 0.0% |
1990 Q2 | - USD | 0.0% |
1990 FY | -2.1 Million USD | -110.0% |
1990 Q1 | - USD | 0.0% |
1990 Q4 | - USD | 0.0% |
1989 Q2 | - USD | 0.0% |
1989 Q3 | - USD | 0.0% |
1989 FY | -1 Million USD | 44.44% |
1989 Q1 | - USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Bionano Genomics, Inc. | -232.49 Million USD | 98.213% |
Prenetics Global Limited | -62.72 Million USD | 93.377% |
Star Equity Holdings, Inc. | -1.54 Million USD | -168.346% |
CareDx, Inc | -190.28 Million USD | 97.817% |
Exact Sciences Corporation | -204.14 Million USD | 97.965% |
Exagen Inc. | -23.68 Million USD | 82.464% |
Inotiv, Inc. | -105.14 Million USD | 96.049% |
Guardant Health, Inc. | -479.44 Million USD | 99.134% |
Biodesix, Inc. | -52.14 Million USD | 92.034% |
BioNexus Gene Lab Corp. | -2.62 Million USD | -58.004% |
Precipio, Inc. | -5.85 Million USD | 29.028% |
iSpecimen Inc. | -11.09 Million USD | 62.575% |
Natera, Inc. | -434.8 Million USD | 99.045% |
Aspira Women's Health Inc. | -16.69 Million USD | 75.111% |
Standard BioTools Inc. | -74.65 Million USD | 94.436% |
23andMe Holding Co. | -666.7 Million USD | 99.377% |
Castle Biosciences, Inc. | -57.46 Million USD | 92.771% |
Personalis, Inc. | -108.29 Million USD | 96.164% |
Aclaris Therapeutics, Inc. | -88.48 Million USD | 95.305% |
Applied DNA Sciences, Inc. | -9.94 Million USD | 58.239% |
OpGen, Inc. | -32.66 Million USD | 87.284% |
T2 Biosystems, Inc. | -50.07 Million USD | 91.705% |
Myriad Genetics, Inc. | -112 Million USD | 96.291% |
ICON Public Limited Company | 612.33 Million USD | 100.678% |
NeoGenomics, Inc. | -87.96 Million USD | 95.278% |
Star Equity Holdings, Inc. | -1.54 Million USD | -168.346% |
IDEXX Laboratories, Inc. | 845.04 Million USD | 100.492% |
RadNet, Inc. | 3.04 Million USD | 236.465% |
MDxHealth SA | -43.1 Million USD | 90.362% |
Illumina, Inc. | -1.16 Billion USD | 99.642% |
Check-Cap Ltd. | -17.56 Million USD | 76.355% |
Twist Bioscience Corporation | -208.72 Million USD | 98.01% |
DarioHealth Corp. | -59.42 Million USD | 93.01% |
Fulgent Genetics, Inc. | -167.82 Million USD | 97.525% |
Sera Prognostics, Inc. | -36.24 Million USD | 88.538% |
ENDRA Life Sciences Inc. | -10.06 Million USD | 58.709% |
OPKO Health, Inc. | -188.86 Million USD | 97.801% |
Medpace Holdings, Inc. | 282.81 Million USD | 101.469% |
Neogen Corporation | -9.42 Million USD | 55.907% |
Intelligent Bio Solutions Inc. | -10.15 Million USD | 59.101% |
Prenetics Global Limited | -62.72 Million USD | 93.377% |
Mainz Biomed B.V. | -26.29 Million USD | 84.203% |
bioAffinity Technologies, Inc. | -7.93 Million USD | 47.663% |
Trinity Biotech plc | -24.01 Million USD | 82.705% |
Neuronetics, Inc. | -30.18 Million USD | 86.24% |
Sotera Health Company | 51.37 Million USD | 108.085% |
bioAffinity Technologies, Inc. | -7.93 Million USD | 47.663% |